Literature DB >> 25771394

Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis.

Kon-Ping Lin1, Pei-Chien Tsai2, Yi-Chu Liao1, Wei-Ting Chen3, Ching-Piao Tsai1, Bing-Wen Soong4, Yi-Chung Lee5.   

Abstract

Mutations in the MATR3 gene were just recently identified to cause familial amyotrophic lateral sclerosis, and their role in amyotrophic lateral sclerosis (ALS) in various populations remains unclear. The aim of this study was to determine the frequency and spectrum of mutations in MATR3 in a Taiwanese ALS cohort of Han Chinese origin. Mutational analyses of MATR3 were carried out by direct nucleotide sequencing in a cohort of 207 unrelated patients with ALS. Among them, the genetic diagnoses of 169 patients remained elusive after mutations in SOD1, C9ORF72, TARDBP, FUS, ATXN2, OPTN, VCP, UBQLN2, SQSTM1, PFN1, HNRNPA1, and HNRNPA2B1 had been excluded. We identified 1 heterozygous missense mutation, p.Ala72Thr (c.214G>A), in 1 patient with bulbar-onset and apparently sporadic ALS. The frequency of MATR3 mutations in ALS patients in Taiwan is, therefore, approximately 0.5% (1 of 207). This study reports a novel MATR3 mutation and stresses on the importance to consider MATR3 mutation as a possible etiology of ALS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; Amyotrophic lateral sclerosis; MATR3; Matrin-3

Mesh:

Substances:

Year:  2015        PMID: 25771394     DOI: 10.1016/j.neurobiolaging.2015.02.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients.

Authors:  Priyam Narain; Aditya K Padhi; Upma Dave; Dibyakanti Mishra; Rohit Bhatia; Perumal Vivekanandan; James Gomes
Journal:  Neurogenetics       Date:  2019-08-20       Impact factor: 2.660

Review 2.  Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.

Authors:  Gerald Pfeffer; Grace Lee; Carly S Pontifex; Roberto D Fanganiello; Allison Peck; Conrad C Weihl; Virginia Kimonis
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

Review 3.  Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications.

Authors:  Ruth Chia; Adriano Chiò; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2017-11-16       Impact factor: 44.182

Review 4.  ALS: Recent Developments from Genetics Studies.

Authors:  Martine Therrien; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 5.  The epidemiology and genetics of Amyotrophic lateral sclerosis in China.

Authors:  Xiaolu Liu; Ji He; Fen-Biao Gao; Aaron D Gitler; Dongsheng Fan
Journal:  Brain Res       Date:  2018-03-01       Impact factor: 3.610

6.  Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.

Authors:  Lihua Hou; Bin Jiao; Tingting Xiao; Lu Zhou; Zhifan Zhou; Juan Du; Xinxiang Yan; Junling Wang; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 7.  Genotype-phenotype correlations of amyotrophic lateral sclerosis.

Authors:  Hong-Fu Li; Zhi-Ying Wu
Journal:  Transl Neurodegener       Date:  2016-02-03       Impact factor: 8.014

Review 8.  Linking hnRNP Function to ALS and FTD Pathology.

Authors:  Maria D Purice; J Paul Taylor
Journal:  Front Neurosci       Date:  2018-05-15       Impact factor: 4.677

9.  ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.

Authors:  Ashley Boehringer; Krystine Garcia-Mansfield; Gurkaran Singh; Nadine Bakkar; Patrick Pirrotte; Robert Bowser
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

10.  Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant.

Authors:  Yu-Shuen Tsai; Kon-Ping Lin; Kang-Yang Jih; Pei-Chien Tsai; Yi-Chu Liao; Yi-Chung Lee
Journal:  Ann Clin Transl Neurol       Date:  2020-05-27       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.